UnitLevel 2Undergraduate

BPS2042 Drug development

Faculty of Pharmacy and Pharmaceutical Sciences

BPS2042 Drug development is a level 2, 6-credit-point, undergraduate unit from the Faculty of Pharmacy and Pharmaceutical Sciences, offered in 2026 in Semester 2 at Malaysia and Parkville. It has no prerequisites.

Credit points
6
Offered in 2026
Semester 2
Malaysia, Parkville
Assessment
No exam
4 tasks

This is the 2026 handbook entry. See the 2027 entry.

Reviews

No reviews yet

No reviews yet. Be the first to review BPS2042.

Overview

This unit will take you through the process of developing a drug candidate into a registered pharmaceutical product. This encompasses: pre-clinical development, including drug formulation based on the pharmacokinetic, pharmacodynamic and toxicological profile of a drug candidate; clinical trial regulation and design; intellectual property and marketing considerations. You will be introduced to the regulatory and commercial requirements as well as the scientific concepts underpinning the drug development processes. This unit also explores a range of career paths available in the pharmaceutical industry.

Offerings in 2026

Teaching periodCampusMode
Second semesterMalaysiaOn campus
Second semesterParkvilleOn campus

Assessment

  • Online quizzesQuiz / Test
    50%
  • Careers AssignmentWritten
    10%
  • Ethics AssignmentWritten
    20%
  • Group PresentationPresentation
    20%

Assessment details may change. Please refer to the assessment information in Moodle closer to the start of the teaching period.

Learning outcomes

When you finish this unit, you should be able to:

  1. 1

    Explain the scientific and regulatory stages involved in taking a drug candidate to a registered pharmaceutical product.

  2. 2

    Explain the basis of pre-formulation tests to inform formulation decisions.

  3. 3

    Evaluate formulation options for a drug candidate with regard to medical, technical and commercialisation considerations.

  4. 4

    Propose pre-clinical tests for a drug candidate to provide evidence for its safety.

  5. 5

    Differentiate between the phases of a clinical trial.

  6. 6

    Discuss the commercial lifecycle of a pharmaceutical product, the importance of intellectual property and marketing considerations.

  7. 7

    Identify and describe a range of jobs that exist in the pharmaceutical industry.

Workload and teaching

  • Workshops26 hours
  • Applied sessions12 hours
  • Teaching approachCase-based teaching
  • Teaching approachActive learning
  • Twelve 1-hour online preparation modules (Discovery)
  • Twenty-four 1-hour interactive online modules
  • Twelve 1-hour applied sessions (Q&A)
  • Eleven 2-hour workshops
  • One 4-hour workshop (GMP)

Workshops will use primarily group work to work through case studies in different aspects of the drug development process

Learning resources

Technology resources

For more information on Bring Your Own Device (BYOD) specifications and the technology systems and services available to students, review the Student Technology Essentials Handbook https://www.monash.edu/__data/assets/pdf_file/0010/1041220/student-it-brochure.pdf

Contacts

Unit Coordinators
Dr Nagashekhara Molugulu
Dr Ian Larson
Chief Examiners
Dr Ian Larson

Common questions

What are the prerequisites for BPS2042?

BPS2042 has no prerequisites.

When is BPS2042 offered?

In 2026, BPS2042 runs in Semester 2 at Malaysia and Parkville.

Does BPS2042 have an exam?

No. BPS2042 has 4 assessment tasks and no exam.

More details

Credit points
6
Level
2
Study level
Undergraduate
Faculty
Faculty of Pharmacy and Pharmaceutical Sciences
Type
Coursework
EFTSL
0.125
Student contribution
SCA Band 2
Study abroad
Available